Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC

CD4 Helper and CD8 Cytotoxic T Cell Differentiation

(2018) Ichiro Taniuchi   Annual Review of Immunology

Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma

(2018) Yujiao Zhou et al.   Journal of Immunology Research

δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8+ T cell activation

(2018) Fei Huang et al.   OncoImmunology

Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma

(2018) Jieyu Li et al.   Cancer Management and Research

Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice

(2017) Zixi Hu et al.   Theranostics

Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma

(2016) Qin Wang et al.   ANNALS OF SURGICAL ONCOLOGY

Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials

(2016) Zhipeng Sun et al.   BioScience Trends

Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma

(2015) Yoshito Tomimaru et al.   VACCINE

Cytotoxic T Lymphocytes Elicited by Dendritic Cell-Targeted Delivery of Human Papillomavirus Type-16 E6/E7 Fusion Gene Exert Lethal Effects on CaSki Cells

(2014) Xiang-Mei Wu et al.   Asian Pacific Journal of Cancer Prevention

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma

(2014) Arihiro Aihara et al.   HEPATOLOGY

Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma

(2014) TIAN XUE et al.   ONCOLOGY REPORTS

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

(2014) Koichi Shimizu et al.   Human Vaccines & Immunotherapeutics

Targeting the Fas/FasL signaling pathway in cancer therapy

(2012) María Villa-Morales et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma

(2012) Masafumi Shimoda et al.   JOURNAL OF HEPATOLOGY

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

(2012) Augusto Villanueva et al.   Nature Reviews Gastroenterology & Hepatology

Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma

(2011) Takehiro Noda et al.   HEPATOLOGY